Invitrogen™ Canine GRO alpha/CXCL1 ELISA Kit

Ref.: BL-RE-092031Manufacturer ref.: EC6RBX5 5 x 96 tests
€2,950.00 excl. VAT

Canine GRO alpha/CXCL1 quantitates canine GRO alpha/CXCL1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant canine GRO alpha/CXCL1.

Accession number
Alpha-chimiokine; C Cmotif chimiokine; C x C motif chimiokine; CC motif chimiokine; CCmotif chimiokine; chimiokine (C-X-C motif) ligand 1; chimiokine (C-X-C motif) ligand 1 (mélanome croissance stimulante, alpha); Cinc1; CCIN-1; CXC; CXC; Chimiokine de motif CXC ; ligand C-X-C de motif chimiokine 1 ; ligand C-X-C de motif chimiokine 1 ; CXCL ; CXCL1 ; CXCL-1 ; chimioattrtant de neutrophile induit par cytokine 1 ; protéine sécrétrice de fibroblastes ; FSP ; gro ; GRO a ; Gro a; Gro1; GRO1 oncogene; GRO1 oncogene (activité stimulante de croissance du mélanome, alpha); GRO1 oncogene (activité stimulante de croissance du mélanome); Groa; GROalpha; GRO-alpha(1-73); GRO-alpha(4-73); Gro-alpha(5-73); GRO-alpha(6-73); protéine alpha régulée par la croissance; Groa; facteur synergique hématopoïétique; HSF; Cb; Cb(5-72); Cb/GR-alpha; Cb/GRO-alpha; C-T; activité stimulante de croissance du mélanome, alpha; activité stimulante de croissance du mélanome; activité stimu
Dose range
5.4 to 350 pg/mL
Sensitivity of the dosage
5.4 pg/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Canine GRO alpha/CXCL1 quantitates canine GRO alpha/CXCL1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant canine GRO alpha/CXCL1.

Canine GRO alpha/CXCL1 quantitates canine GRO alpha/CXCL1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant canine GRO alpha/CXCL1.

CXCL1, CXCL2 and CXCL3, also known as GRO alpha, GRO beta (MIP-2 alpha) and GRO gamma (MIP-2 beta), are members of the CXC chemokin subfamily. CXCL1/2/3 mature proteins bind with a high affinity to the IL-8 type B receptor and are powerful neutrophil attractants and activators. In vitro, the treated forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) showed 30 times higher chemotactic activity.

Sensitivity

Sensitivity of dosage: 5.4 pg/mL.

Measurement range

Dose range: 5.4 to 350 pg/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CXCL (GRO alpha).

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17134809
Specifications
Accession numberAlpha-chemiokin; C Chimokin Cmotif; C x C chemokine pattern; CC chemokine pattern; CCmotif chemokine; chemokine (C-X-C motif) ligand 1; chemokine (C-X-C motif) ligand 1 (stimulating growth melanoma, alpha); Cinc1; CCIN-1; CXC; CXC; Chimiokine pattern CXC; C-X-C pattern ligand chemokin 1
Dose range5.4 to 350 pg/mL
Sensitivity of the dosage5.4 pg/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCXCL (GRO alpha)
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EC6RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.